Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,824 stories, page 477 of 698

Advanced search

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech AG Receives Scientific Advice from Germany’s PEI on BiTAC-TCE Development Program

Quiver QuantitativeOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Armata submits Phase 3 protocol for antibiotic-resistant drug

Investing.comOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan

The Manila TimesOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

INmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for CORDStrom™ Platform

The Manila TimesOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans

The Manila TimesOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World's Premier Scientific Meetings in Oncology

The Manila TimesOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Pune: FDA’s AI Complaint Portal Receives 293 Food And Drug Complaints In Four Days

PUNE PULSEOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Can AI Fix Pharma's Last-Mile Delivery Blind Spot?

PharmTech.comOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

UK biotech financing continues recovery trajectory on five-year Q2 high

Yahoo FinanceOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Can-Fite BioPharma (NYSE: CANF) to present Phase 2a pancreatic cancer data

Stock TitanOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

‘Systemic leap’: China’s drug innovation push yields bumper crop

South China Morning PostOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Pancreatic cancer patient alive 18+ months after second-line Namodenoson

Stock TitanOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

INmune Bio's Cord-Tissue Process Supports Planned Phase 3 Trial

Stock TitanOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Compugen's Cancer Immunotherapy Update Is Set for Aug. 3

Stock TitanOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

VERAXA cancer candidate targets two markers while sparing others

Stock TitanOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Clinigen Appoints Greg Skalicky as Chief Executive Officer

Business WireOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Armata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02

Yahoo! Finance CanadaOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

OKYO Pharma LTD

Via RitzauOriginal source

🌍Jul 20Industryir.biolinerx.comTier 1 · Company source

BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026

BioLineRxOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Betting on biotech: Clinical trials enter prediction markets

medwatch.comOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Manufacturing ChemistOriginal source

🇺🇰Jul 20Regulatorygov.ukTier 1 · Regulatory source

UKHSA's Chief Scientist reminds families how to Beat the Heat as schools break for summer

UKHSA joins forces with leading water safety charities to highlight the risks of swimming in open wa...

UK Health Security AgencyOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of HOB Biotech Group Corp., Ltd. Class A – SSE:688656

TradingViewOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Sound Shore Management Inc. CT Lowers Position in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

WCM Investment Management LLC Purchases 26,813,522 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🌍Jul 20discoverynews.google.comTier 2 · Trade media

UK biotech financing continues recovery trajectory on five-year Q2 high

Pharmaceutical TechnologyOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

4DMT Reports Positive 2-Year PRISM Phase 2b Data for 4D-150

t.coOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Xencor Shares Kidney Cancer Trial Results at ESMO

t.coOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Inflammasome Reports Positive Phase 2 K8 Results

t.coOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Eli Lilly Bets $3.8 Billion on AtaiBeckley Psychedelics

WhalesbookOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

The patient information leaflet: is it really working for patients?

The Pharmaceutical JournalOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Biotech Breakthroughs in Treating Uterine Disorders

BBN TimesOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Price to book forward of HOB Biotech Group Corp., Ltd. Class A – SSE:688656

TradingViewOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals (ASX:RCE): Share Purchase Plan Deadline Extended---What Investors Need to Know

KalkineOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

DWWD ETF Profile: Dividends, Returns (HAN:DWWD)

TradingViewOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?

Pharmaceutical ExecutiveOriginal source

🇿🇦Jul 20Regulatorysahpra.org.zaTier 1 · Regulatory source

SAHPRA Inspires Rhodes Science Students to Shape the Future of Health Regulation

SAHPRA South AfricaOriginal source

🇺🇸Jul 20Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Comparison of Initial Artificial Intelligence (AI) and Final Physician Recommendations in AI-Assisted Virtual Urgent Care Visits

PubMed Annals of Internal Medicine RSSOriginal source

🇺🇸Jul 20Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Olorofim in Treatment of Patients With Poorly Controlled Disseminated Coccidioidomycosis : A Single-Group, Open-Label, Phase 2b, Multicenter Study

PubMed Annals of Internal Medicine RSSOriginal source

🇺🇸Jul 20Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Strengthening the Reporting of Observational Studies in Epidemiology Enhanced Prevalence and Incidence Criteria (STROBE EPIC): An Extension of the STROBE Statement

PubMed Annals of Internal Medicine RSSOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Critical Medicines on Hold: Pakistan's Regulatory Gridlock Risking Lives

DevdiscourseOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Lecanemab for AD Shows Sustained Benefit in Real-World Study

MedscapeOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

FDA Crackdown: Tukaram Mundhe Reveals Maharashtra's Biggest Food Complaint Hotspot

NDTV ProfitOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

BlossomHill joins biotech IPO stampede with small molecule bet

The Pharma LetterOriginal source

🇺🇰Jul 20Regulatorygov.ukTier 1 · Regulatory source

Weekly all-cause mortality surveillance: week ending 19 July 2026

How the actual number of deaths in England compare with expected numbers for each week.

UK Health Security AgencyOriginal source

🇺🇰Jul 20Researched.ac.ukTier 2 · Direct publisher

Test points to precision treatment for autoimmune condition

University of EdinburghOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

A look: Cleanroom technology events 2026-2027

Scientist LiveOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

UK biotech venture investment reaches five-year high in Q2 2026

The Pharma LetterOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

India approves first dengue vaccine QDENGA for people aged 4-60 years

The Hans IndiaOriginal source

🇺🇰Jul 20Regulatorygov.ukTier 1 · Regulatory source

Meningococcal B (MenB) time limited vaccination offer: information for healthcare practitioners

Guidance for health professionals delivering the time-limited MenB vaccination offer for year 13 age...

UK Health Security AgencyOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

What to know about the seven peptides an FDA advisory panel is set to review this week

NBC NewsOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Latigo bets its IPO on non-opioid pain data

The Pharma LetterOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Galderma rolls out Alastin regenerative skincare across JPAC region

The Pharma LetterOriginal source

🌍Jul 20discoverynews.google.comTier 2 · Trade media

UK biotech venture investment remains buoyant in Q2

pharmaphorumOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Dyslipidemia, which is familiar with hyperlipidemia, is considered a "national chronic disease" alon..

매일경제Original source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe: Maharashtra FDA's Food Safety Enforcement Drive

The Chenab TimesOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

UBFC ETF Profile: Dividends, Returns (SWB:UBFC)

TradingViewOriginal source

🌍Jul 20discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene's TG-C Fails to Meet Statistical Significance in U.S. Phase 3

Seoul Economic DailyOriginal source

🇺🇰Jul 20Regulatorygov.ukTier 1 · Regulatory source

Flu vaccines for children and young people for 2026 to 2027

A quick reference guide to the childhood flu vaccines for winter 2026 to 2027.

UK Health Security AgencyOriginal source

🇺🇰Jul 20Regulatorygov.ukTier 1 · Regulatory source

Flu vaccination: letter template for at risk patients and carers

Template for GPs to invite patients at risk of flu due to a medical condition or age, and their care...

UK Health Security AgencyOriginal source